# SpectrumAi

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spectrumai

- Industry: Healthcare Specialists
- Headquarters: Los Angeles, US
- Website: www.spectrumai.com/
- Total disclosed funding: $29M
- Latest round: Series A (Mar 16, 2023)
- Investors on record: 5

## About

Founded in 2021 and based in California, US, SpectrumAi operates as a provider of AI-based treatment for a person with autism. In?August 2025,?CentralReach, LLC acquired SpectrumAi from?Autism Impact Fund, F-Prime Capital, Frist Cressey Ventures, Cobalt Ventures, and CVS Health Ventures. Financial terms were not disclosed. The company is led by founder and CEO, Ling Shao.

SpectrumAi offers tools and solutions to improve autism care by building a compelling product to enable higher-quality care through better workflows and data science. Thus, the company seeks to improve data capture and bring objective measurement to ABA (Applied Behavior Analysis) therapy in the autism space. Additionally, SpectrumAi’s target clientele is ABA therapy providers seeking to modernize their session management practices and better track treatment. The company plans to use the 2022 funding to accelerate the adoption of its ABA electronic health record, Twyll, and its network analytics platform, Patterns.

## Funding rounds

- Series A, Mar 16, 2023, $20M — F-Prime Capital, Frist Cressey Ventures, Cobalt Ventures, CVS Health Ventures, Autism Impact Fund
- Seed, Jun 1, 2022, $9M — F-Prime Capital, Frist Cressey Ventures, Autism Impact Fund

## Investors

- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Seed, Series A
- Frist Cressey Ventures (https://capitalatlas.ai/funds/frist-cressey-ventures) — Seed, Series A
- Autism Impact Fund (https://capitalatlas.ai/funds/autism-impact-fund) — Seed, Series A
- Cobalt Ventures (https://capitalatlas.ai/funds/cobalt-ventures) — Series A
- CVS Health Ventures (https://capitalatlas.ai/funds/cvs-health-ventures) — Series A